Schrödinger Announces the Release of FirstDiscovery 1.8
The unparalleled accuracy obtained using the FirstDiscovery suite complements and can greatly enhance current drug discovery efforts. Addressing some of the specific problems in experimental drug design, the FirstDiscovery suite:
reliably identifies lead compounds that meet stringent criteria early in the drug discovery process, supports experimental high-throughput screening (HTS), even when it is otherwise too expensive, too time consuming, or not available, increases the quality of candidates that proceed into lead optimization and development.
The FirstDiscovery suite includes Glide and QikProp, for high throughput library screening via binding affinity or pharmacokinetic properties, respectively. For lead optimization, FirstDiscovery includes Liaison, which elucidates contributions to binding affinity for drug candidates to within chemical accuracy, and QSite, which performs in-depth analysis of active-site chemistry. FirstDiscovery 1.8 is available for the SGI IRIX and PC Linux platforms.
Most read news
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.